tablet-yellow

Bupivacaine Liposome (Exparel)

Anesthesia Implications

Clinically reviewed by anesthesia providers · Updated

Classification:
Amide local anesthetic, liposomal extended-release formulation, long-acting
Therapeutic Effects:
Prolonged local anesthesia and postoperative analgesia (up to 72 h)
Primary Considerations:

Surgical infiltration - Injected into the surgical site for postoperative analgesia lasting up to 72 h; single-dose maximum 266 mg (20 mL). Approved blocks - FDA -approved for interscalene brachial...

Continue reading

Read the full drug post with a free account

Free. It opens every drug, surgery and condition in the library.

Already have an account?